Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. - Wikidata - wikimedia - TriplyDB

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

http://www.wikidata.org/entity/Q38050961

about

Corticosteroid therapy for nephrotic syndrome in children Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children History of Nephrotic Syndrome and Evolution of its Treatment The non-immunosuppressive management of childhood nephrotic syndrome Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis.A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: Susceptibility and steroid responsiveness In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome.Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality.The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis.Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort Occurrence of common allergic diseases in children with idiopathic nephrotic syndrome.Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission.Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors.Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease.Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis.Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date.Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.Genetics of childhood steroid-sensitive nephrotic syndrome.Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.Nephrotic syndrome in infants and children: pathophysiology and management.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease.B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.Advances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, nutrition, pulmonology.The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective.Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome.Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS.Steroid-induced impairment of glucose tolerance: Prevalence among pediatric patients on long-term steroid use in Nigeria.Tuberculosis infection in children with proteinuria/nephrotic syndrome.Paediatric nephrology: the last 50 years.The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.

P2860

Q24187231-002A8BAF-D23E-431C-9C04-0A5F3768E596 Q24202861-C9DE1263-C86A-408A-AB54-278B8759FA50 Q26745891-773D64F3-1E14-4985-8433-D66E692BDBA0 Q26778157-480FAC23-2290-4C75-A27E-E83CBCEBA57D Q30240107-165A3D81-6E5D-4B69-82EB-247E4C0D365A Q33818184-7BDC4DEC-67DF-48D6-857B-4380DC1B89C3 Q34519514-3534CAC1-7AED-463E-85D6-408EB2937023 Q34558874-9B4B4D9C-AAEC-4DF1-8454-7696E69F33C4 Q35040896-1D207C8A-B26E-4F25-BDE3-6F6F039135CE Q35233125-A9C8D250-A284-423E-AB22-ACED8CF5D22C Q35278415-F9772111-4D21-4A69-9117-E8801FE7135F Q35543061-873408EE-0427-4076-86E9-C4727DF91DC1 Q35712990-E9103C40-97BB-44EE-8CED-70465354A2A5 Q35876989-2472315E-BC41-4636-9F51-5B04A81AB8E8 Q36322955-ADC16C67-C585-4549-AC0F-B98BFB6E3515 Q37261621-89E727D3-C6E4-414E-895E-2E811D5661C2 Q37680867-4EFA4A59-97F4-4B70-89F7-C323C8E02CEA Q37689858-4DA61145-E589-4611-8C13-469E3C9DBCB1 Q38050959-E344E14A-D82B-4764-928F-72201A2435AF Q38132611-55B55CB6-DD4B-4CA5-83F1-70A5866139B7 Q38191615-C7A9E31A-C123-4B71-A14C-BED7B9BE0D3C Q38569641-17F31DC3-FE3A-4E74-9A8F-6866C8371A79 Q38662074-F4FA16DB-9417-42B8-A550-69E5CE9D1F8F Q38867651-1ABD6E82-A9EC-471C-9D25-3494464BF902 Q38911915-89D64B55-38FB-4D8D-A761-E00BDCBF1D9B Q39827261-6E354569-8027-46C2-BBB2-2A0D330F242B Q40035174-298C350A-9D6B-426E-AAEC-9A46BC8C4676 Q40039238-538A9781-A7F6-4537-B76C-F1D6138B152F Q40193019-F2406E66-6D80-4581-9CC8-5B8046960AF8 Q40369592-1CD2FEE7-36F4-40B4-B8ED-D9194ACA201A Q41124267-F9BFDCE2-3942-4D72-916E-A560BA300F18 Q41602217-96BA3DEB-39AC-432A-A53D-F364F0265447 Q41714358-5DEE9F9A-BDD0-4FF1-92B2-AADD37166931 Q42424215-3B862C8E-7990-4B6E-9AEF-97B7A520E1EB Q45836604-146099D1-A96D-4821-981A-E703B519D955 Q46284598-27A19549-CDB2-4A4C-9FC5-D5FF32C42408 Q46800535-B476D08E-9D3F-40BA-AE4A-44480521ECD7 Q47097995-DDB35FE0-E370-48BB-8224-2DFBC53834D4 Q48055250-C70F6F42-A609-4C8A-BFBA-2599ADCCCD4F Q48097764-68E09AFB-41FA-4B11-8DCF-6714B4E4189A

P2860

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

http://www.wikidata.org/entity/Q38050961

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

@en

type

label

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

@en

prefLabel

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

@en

P1433

Q38050961-5091A994-5446-4292-A36D-26D2BCB190E4

P1476

Q38050961-E329BB2A-9C8C-44A1-8BAA-17FBD66FF940

P2093

Q38050961-34F3494C-5B72-4F25-8F84-3DDA57E4D399

Q38050961-4571ECAA-BE52-4E5B-8043-1DF49B8E70B1

Q38050961-90BFAC76-680C-4681-8DF2-E67985FD9351

P2860

Q38050961-03002A36-9E02-46A5-90D8-07268007930C

Q38050961-09ED4A01-7730-461A-A51A-7334E54A9393

Q38050961-107C9472-02EA-4178-ACDB-4220C0FE357C

Q38050961-12BC4355-832D-4B97-9EA2-1DF2C5AC8F48

Q38050961-23CA4E22-EDF0-4671-B2EE-140BE6CE4303

Q38050961-31C39410-6075-4D62-AAC2-4743D90F4A06

Q38050961-358C4A56-A211-4C2A-85D2-5B72F6DA5607

Q38050961-43EC1C3D-0A3A-4D07-A864-EBA0F3751C52

Q38050961-5B5C80D2-E804-4637-8071-5B694558ABA0

Q38050961-5BBA4D68-ABBE-411B-9CB4-7B4034242BB7

P2888

Q38050961-A946F8F9-230B-42A3-98B4-30E605F010D2

P304

Q38050961-40387168-D309-4630-93ED-DA8E64494290

P31

Q38050961-572158A3-A816-442C-BF11-6AE8D7FED224

P356

Q38050961-438012AB-3161-45AA-B528-D68B0F112A44

P433

Q38050961-2C593965-27C3-43A5-B877-827DED4480F3

P478

Q38050961-BB4374F8-E08E-48E0-858D-16A9C796A441

P50

Q38050961-010FDB27-529C-43C6-A8CB-CBA3EE1C518E

P577

Q38050961-149B9753-66AB-49EB-9054-A650B7602374

P5875

Q38050961-4C60567A-0C58-468B-B9B5-0AFDC4480CFF

P6179

Q38050961-C62D3CAB-8E98-4CC6-9652-6D102FC5C7D4

P698

Q38050961-3AEBB89C-F8E0-4E33-B7B2-A60D0470B2DC

P356

S00467-012-2310-X

P1433

Pediatric Nephrology

P1476

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

@en

P2093

Elisabeth M Hodson

http://www.w3.org/2001/XMLSchema#string

Kidney Disease: Improving Global Outcomes

http://www.w3.org/2001/XMLSchema#string

Rebecca M Lombel

http://www.w3.org/2001/XMLSchema#string

P2860

Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Long-term outcome of primary nephrotic syndrome.

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.

Going from evidence to recommendations.

Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?

Management of childhood onset nephrotic syndrome.

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Side effects of levamisole in children with nephrosis.

P2888

s00467-012-2310-x

P304

415-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-012-2310-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Debbie S Gipson

P577

2012-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232229358

http://www.w3.org/2001/XMLSchema#string

P6179

1053568401

http://www.w3.org/2001/XMLSchema#string

P698

23052651

http://www.w3.org/2001/XMLSchema#string